Emerging therapies for hemophilia: controversies and unanswered questions

Emerging and future therapies for hemophilia

The evolution of care in hemophilia is a remarkable story. Over the last 60 years, advances in protein purification, protein chemistry, donor screening, viral inactivation, gene sequencing, gene cloning, and recombinant protein production have dramatically enhanced the treatment and lives of patients with hemophilia. Recent efforts have produced enhanced half-life (EHL) clotting factors to bett...

Emotion theory and research: highlights, unanswered questions, and emerging issues.

Emotion feeling is a phase of neurobiological activity, the key component of emotions and emotion-cognition interactions. Emotion schemas, the most frequently occurring emotion experiences, are dynamic emotion-cognition interactions that may consist of momentary/situational responding or enduring traits of personality that emerge over developmental time. Emotions play a critical role in the evo...

E-Learning: some unanswered questions

Emerging Drug Therapies for Heart Failure

Heart failure is associated with high morbidity and mortality and is proving to be an economic burden in developing countries. A number of therapeutic agents are presently employed in heart failure; but they are not sufficient to control symptoms of heart failure. Moreover, the prevalence of chronic heart failure is progressively increasing and thus there is a continuing need to develop effecti...

Yoga: Some Unanswered Questions

Grover et al (1994) have provided an excellent and thought provoking analysis of the usefulness of yoga in treating neurotic disorders. Some questions however remain. One criticism of psychotherapy is that the criteria for the selection of suitable candidates usually identify patients with good prognostic features-patients who may improve even without any therapeutic intervention. Another criti...